Cargando…

Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS‐CoV‐2 IgG and IgM

BACKGROUND: Seldom performance evaluation and diagnosis comparison studies were reported for different chemiluminescent immunoassay (CLIA) kits approved under an emergency approval program for SARS‐CoV‐2 infection. METHODS: A total of 100 and 105 serum separately from non‐infected populations and CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, Xiaowen, Wang, Enyun, Hu, Jiwen, Zong, Zengyan, Jiang, Ruiwei, Wang, Mengmeng, Kan, Lijuan, Zhang, Xiuming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843253/ https://www.ncbi.nlm.nih.gov/pubmed/33340166 http://dx.doi.org/10.1002/jcla.23681

Ejemplares similares

Dynamic observation of SARS‐CoV‐2 IgM, IgG, and neutralizing antibodies in the development of population immunity through COVID‐19 vaccination
por: Jiang, Ruiwei, et al.
Publicado: (2022)

Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID‐19 cohorts by chemiluminescent immunoassays
por: Dou, Xiaowen, et al.
Publicado: (2022)

Distribution characteristics of SARS-CoV-2 IgM/IgG in false-positive results detected by chemiluminescent immunoassay
por: Lei, Yan, et al.
Publicado: (2022)

Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world
por: Li, Min, et al.
Publicado: (2022)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG
por: Gambino, Caterina Maria, et al.
Publicado: (2020)

Diagnostic performance of an automated chemiluminescence immunoassay for SARS-CoV-2 IgG and IgM antibodies detection: A real life experience
por: Villalta, Danilo, et al.
Publicado: (2021)

Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay
por: Zhou, Jin-an, et al.
Publicado: (2021)

Enzyme-linked immunoassay for dengue virus IgM and IgG antibodies in serum and filter paper blood
por: Tran, Thanh Nga T, et al.
Publicado: (2006)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2021)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection
por: Kikuti, Mariana, et al.
Publicado: (2018)

Diagnostic accuracy of an in-house Scrub Typhus enzyme linked immunoassay for the detection of IgM and IgG antibodies in Laos
por: Elders, Philip N. D., et al.
Publicado: (2020)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Helper T cells reacting to idiotype on IgG but not IgM
Publicado: (1985)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020)

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)

Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test
por: Diani, Erica, et al.
Publicado: (2021)

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

Rheumatoid factor IgM autoantibodies control IgG homeostasis
por: Nicolò, Antonella, et al.
Publicado: (2022)

Patterns of IgG and IgM antibody response in COVID-19 patients
por: Liu, Xuemei, et al.
Publicado: (2020)

IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis
por: Feng, Xiaoyan, et al.
Publicado: (2014)

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

In Men at Risk of HIV Infection, IgM, IgG1, IgG3 and IgA Reach the Human Foreskin Epidermis
por: Lemos, Maria P., et al.
Publicado: (2015)

Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015)

MONOCLONAL PRODUCTION OF BOTH IgM AND IgG1 ANTIHAPTEN ANTIBODY
por: Press, Joan L., et al.
Publicado: (1973)

IgG and IgM autoantibody differences in discoid and systemic lupus patients
por: Chong, Benjamin F., et al.
Publicado: (2012)

Simultaneous Quantification of Anticardiolipin IgG and IgM by Time Resolved Fluoroimmunoassay
por: Hu, Zhigang, et al.
Publicado: (2016)

Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia
por: Hii, Shirley Yi Fen, et al.
Publicado: (2017)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Erratum: Rheumatoid factor IgM autoantibodies control IgG homeostasis
Publicado: (2022)

Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries
por: Begeman, Ian J., et al.
Publicado: (2017)

Evaluation of Four Commercial IgG- and IgM-specific Enzyme Immunoassays for Detecting Mycoplasma pneumoniae Antibody: Comparison with Particle Agglutination Assay
por: Yoo, Soo Jin, et al.
Publicado: (2007)

Evaluation of a Newly Developed Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect IgG and IgM Antibodies to Chikungunya Virus
por: Lee, Hyeyoung, et al.
Publicado: (2020)

Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
por: Nedelcu, Iulia, et al.
Publicado: (2021)

A Microflow Cytometry-Based Agglutination Immunoassay for Point-of-Care Quantitative Detection of SARS-CoV-2 IgM and IgG
por: Qu, Jianxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nv64a16r9h1v1k74ten9c190hk